{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T08:58:31Z","timestamp":1773046711966,"version":"3.50.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1007\/s11739-012-0805-x","type":"journal-article","created":{"date-parts":[[2012,10,17]],"date-time":"2012-10-17T12:34:49Z","timestamp":1350477289000},"page":"233-240","source":"Crossref","is-referenced-by-count":5,"title":["The risk stratification in atrial fibrillation"],"prefix":"10.1007","volume":"7","author":[{"given":"Domenico","family":"Prisco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Cenci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Silvestri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Emmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Barnini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Tamburini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,17]]},"reference":[{"key":"805_CR1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cpcardiol.2004.09.002","volume":"30","author":"A Hersi","year":"2005","unstructured":"Hersi A, Wyse DG (2005) Management of atrial fibrillation. Curr Probl Cardiol 30:175\u2013234","journal-title":"Curr Probl Cardiol"},{"key":"805_CR2","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","volume":"285","author":"AS Go","year":"2001","unstructured":"Go AS, Hylek EM, Phillips KA et al (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 285:2370\u20132375","journal-title":"JAMA"},{"key":"805_CR3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.105.595140","volume":"114","author":"Y Miyasaka","year":"2006","unstructured":"Miyasaka Y, Barnes ME, Gersh BJ et al (2006) Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114:119\u2013125","journal-title":"Circulation"},{"key":"805_CR4","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0140-6736(11)61514-6","volume":"379","author":"GY Lip","year":"2012","unstructured":"Lip GY, Tse HF, Lane DA (2012) Atrial fibrillation. Lancet 379:648\u2013661","journal-title":"Lancet"},{"key":"805_CR5","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","volume":"22","author":"PA Wolf","year":"1991","unstructured":"Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22:983\u2013988","journal-title":"Stroke"},{"key":"805_CR6","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1053\/euhj.2001.2983","volume":"22","author":"V Fuster","year":"2001","unstructured":"Fuster V, Ryden LE, Asinger RW et al (2001) ACC\/AHA\/ESC Guidelines for the management of patients with Atrial Fibrillation. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the management of patients with Atrial Fibrillation) developed in collaboration with North American Society of Pacing and Electrophysiology. Eur Heart J 22:1852\u20131923","journal-title":"Eur Heart J"},{"key":"805_CR7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/clc.20969","volume":"35","author":"GY Lip","year":"2012","unstructured":"Lip GY (2012) Can we predict stroke in atrial fibrillation? Clin Cardiol 35:21\u201327","journal-title":"Clin Cardiol"},{"key":"805_CR8","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/01.CIR.0000145172.55640.93","volume":"110","author":"BF Gage","year":"2004","unstructured":"Gage BF, van Walraven C, Pearce L et al (2004) Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 110:2287\u20132292","journal-title":"Circulation"},{"key":"805_CR9","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1161\/STROKEAHA.107.501825","volume":"39","author":"Stroke Risk in Atrial Fibrillation Working Group","year":"2008","unstructured":"Stroke Risk in Atrial Fibrillation Working Group (2008) Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation. Stroke 39:1901\u20131910","journal-title":"Stroke"},{"key":"805_CR10","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.amjmed.2009.12.013","volume":"123","author":"GY Lip","year":"2010","unstructured":"Lip GY, Halperin JL (2010) Improving stroke risk stratification in atrial fibrillation. Am J Med 123:484\u2013488","journal-title":"Am J Med"},{"key":"805_CR11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1160\/TH07-08-0508","volume":"99","author":"M Hughes","year":"2008","unstructured":"Hughes M, Lip GYH, Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care (2008) Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data. Thromb Haemost 99:295\u2013304","journal-title":"Thromb Haemost"},{"key":"805_CR12","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.STR.30.6.1223","volume":"30","author":"RG Hart","year":"1999","unstructured":"Hart RG, Pearce LA, Mc Bride R et al (1999) Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAFI-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Stroke 30:1223\u20131229","journal-title":"Stroke"},{"key":"805_CR13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0735-1097(99)00489-1","volume":"35","author":"RG Hart","year":"2000","unstructured":"Hart RG, Pearce LA, Rothbart RM et al (2000) Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 35:183\u2013187","journal-title":"J Am Coll Cardiol"},{"key":"805_CR14","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.290.8.1049","volume":"290","author":"TJ Wang","year":"2003","unstructured":"Wang TJ, Massaro JM, Levy D et al (2003) A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. J Am Med Assoc 290:1049\u20131056","journal-title":"J Am Med Assoc"},{"key":"805_CR15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/01.STR.26.5.801","volume":"26","author":"JC Latum Van","year":"1995","unstructured":"Van Latum JC, Koudstaal PJ, Venables GS et al (1995) Predictors of major vascular events in patients with a transient ischemic attack or minor ischemic stroke and with non rheumatic atrial fibrillation. European Atrial Fibrillation Trial (EAFT) Study Group. Stroke 26:801\u2013806","journal-title":"Stroke"},{"key":"805_CR16","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/0002-9149(90)90323-S","volume":"65","author":"HS Cabin","year":"1990","unstructured":"Cabin HS, Clubb KS, Hall C et al (1990) Risk for systemic embolization of atrial fibrillation without mitral stenosis. Am J Cardiol 65:1112\u20131116","journal-title":"Am J Cardiol"},{"key":"805_CR17","first-page":"1273","volume":"279","author":"The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators","year":"1998","unstructured":"The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators (1998) Patients with non valvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. J Am Geriat Soc 279:1273\u20131277","journal-title":"J Am Geriat Soc"},{"key":"805_CR18","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/archinte.1990.00390160077016","volume":"150","author":"P Petersen","year":"1990","unstructured":"Petersen P (1990) Risk factors for thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Arch Int Med 150:819\u2013821","journal-title":"Arch Int Med"},{"key":"805_CR19","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0002-8703(98)70231-5","volume":"136","author":"H Nakagami","year":"1998","unstructured":"Nakagami H, Yamamoto K, Ikeda U et al (1998) Mitral regurgitation reduces the risk of stroke in patients with non rheumatic atrial fibrillation. Am Heart J 136:528\u2013532","journal-title":"Am Heart J"},{"key":"805_CR20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0002-9149(89)90349-4","volume":"63","author":"WS Aronow","year":"1989","unstructured":"Aronow WS, Gutstein H, Hsieh FY (1989) Risk factors for thromboembolic stroke in elderly patients with chronic atrial fibrillation. Am J Cardiol 63:366\u2013367","journal-title":"Am J Cardiol"},{"key":"805_CR21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0002-9149(98)00247-1","volume":"82","author":"WS Aronow","year":"1998","unstructured":"Aronow WS, Ahn C, Kronzon I (1998) Risk factors for new thromboembolic stroke in patients \u226462\u00a0years of age with chronic atrial fibrillation. Am J Cardiol 82:119\u2013121","journal-title":"Am J Cardiol"},{"key":"805_CR22","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jacc.2007.09.065","volume":"51","author":"MC Fang","year":"2008","unstructured":"Fang MC, Go AS, Chang Y, The ATRIA Study Group et al (2008) Comparison of risk stratification schemes to predict thromboembolism in people with non-valvular atrial fibrillation. J Am Coll Cardiol 51:810\u2013815","journal-title":"J Am Coll Cardiol"},{"key":"805_CR23","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/STROKEAHA.106.477133","volume":"38","author":"L Baruch","year":"2007","unstructured":"Baruch L, Gage BF, Horrow J et al (2007) Can patients at elevated risk of stroke treated with anticoagulants be further risk stratified? Stroke 38:2459\u20132463","journal-title":"Stroke"},{"key":"805_CR24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1538-7836.2010.04085.x","volume":"9","author":"TP Staa van","year":"2011","unstructured":"van Staa TP, Setakis E, Di Tanna GL et al (2011) A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice. J Thromb Haemost 9:39\u201348","journal-title":"J Thromb Haemost"},{"key":"805_CR25","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S1474-4422(07)70264-8","volume":"6","author":"GYH Lip","year":"2007","unstructured":"Lip GYH, Lim HS (2007) Atrial fibrillation and stroke prevention. Lancet Neurol 6:981\u2013993","journal-title":"Lancet Neurol"},{"key":"805_CR26","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","volume":"154","author":"Atrial Fibrillation Investigators","year":"1994","unstructured":"Atrial Fibrillation Investigators (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 154:1449\u20131457","journal-title":"Arch Intern Med"},{"key":"805_CR27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1052-3057(10)80166-1","volume":"5","author":"Stroke Prevention in Atrial Fibrillation Investigators","year":"1995","unstructured":"Stroke Prevention in Atrial Fibrillation Investigators (1995) Risk factors for thromboembolism during aspirin therapy in patients with atrial fibrillation: the Stroke Prevention in Atrial Fibrillation Study. J Stroke Cerebrovasc Disord 5:147\u2013157","journal-title":"J Stroke Cerebrovasc Disord"},{"key":"805_CR28","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(96)03487-3","volume":"348","author":"Stroke Prevention in Atrial Fibrillation investigators","year":"1996","unstructured":"Stroke Prevention in Atrial Fibrillation investigators (1996) Adjusted dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomized clinical trial. Lancet 348:633\u2013638","journal-title":"Lancet"},{"key":"805_CR29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1378\/chest.126.3_suppl.429S","volume":"126","author":"DE Singer","year":"2004","unstructured":"Singer DE, Albers G, Dalen J et al (2004) Antithrombotic therapy in atrial fibrillation. The Seventh ACCP Conference of Antithrombotic and Thrombolytic Therapy. Chest 126:429\u2013456","journal-title":"Chest"},{"key":"805_CR30","unstructured":"National Collaborating Centre for Chronic Conditions Atrial Fibrillation (2006) National Clinical Guideline for Management in Primary and Secondary Care. London Royal College of Physicians"},{"key":"805_CR31","doi-asserted-by":"crossref","first-page":"546S","DOI":"10.1378\/chest.08-0678","volume":"133","author":"DE Singer","year":"2008","unstructured":"Singer DE, Albers GW, Dalen JE et al (2008) Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:546S\u2013592S","journal-title":"Chest"},{"key":"805_CR32","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/eurheartj\/ehl176","volume":"27","author":"V Fuster","year":"2006","unstructured":"Fuster V, Ryden LE, Cannom DS et al (2006) Task Force on Practice Guidelines, American College of Cardiology\/American Heart Association; Committee for Practice Guidelines, European Society of Cardiology; European Heart Rhythm Association; Heart Rhythm Society. ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 27:1979\u20132030","journal-title":"Eur Heart J"},{"key":"805_CR33","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","volume":"285","author":"BF Gage","year":"2001","unstructured":"Gage BF, Waterman AD, Shannon W et al (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. J Am Med Assoc 285:2864\u20132870","journal-title":"J Am Med Assoc"},{"key":"805_CR34","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1161\/STROKEAHA.110.602987","volume":"42","author":"YD Kim","year":"2011","unstructured":"Kim YD, Cha MJ, Kim J et al (2011) Increases in cerebral atherosclerosis according to CHADS2 scores in patients with stroke with nonvalvular atrial fibrillation. Stroke 42:930\u2013934","journal-title":"Stroke"},{"key":"805_CR35","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1378\/chest.10-1408","volume":"139","author":"JM Ruiz-Nodar","year":"2011","unstructured":"Ruiz-Nodar JM, Mar\u00edn F, Manzano-Fern\u00e1ndez S et al (2011) An evaluation of the CHADS2 stroke risk score in patients with atrial fibrillation who undergo percutaneous coronary revascularization. Chest 139:1402\u20131409","journal-title":"Chest"},{"key":"805_CR36","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1160\/TH11-02-0061","volume":"106","author":"C Keogh","year":"2011","unstructured":"Keogh C, Wallace E, Dillon C et al (2011) Validation of the CHADS2 clinical prediction rule to predict ischaemic stroke. A systematic review and meta-analysis. Thromb Haemost 106:528\u2013538","journal-title":"Thromb Haemost"},{"key":"805_CR37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1160\/TH09-11-0757","volume":"104","author":"G Karthikeyan","year":"2010","unstructured":"Karthikeyan G, Eikelboom JW (2010) The CHADS2 score for stroke risk stratification in atrial fibrillation: friend or foe? Thromb Haemost 104:45\u201348","journal-title":"Thromb Haemost"},{"key":"805_CR38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R et al (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest 137:263\u2013272","journal-title":"Chest"},{"key":"805_CR39","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/bmj.d124","volume":"342","author":"JB Oelsen","year":"2011","unstructured":"Oelsen JB, Lip GY, Hansen ML et al (2011) Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 342:124","journal-title":"BMJ"},{"key":"805_CR40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1378\/chest.11-0862","volume":"141","author":"JB Olesen","year":"2012","unstructured":"Olesen JB, Fauchier L, Lane DA et al (2012) Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation. The Loire Valley Atrial Fibrillation Project. Chest 141:147\u2013153","journal-title":"Chest"},{"key":"805_CR41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1160\/TH08-09-0592","volume":"101","author":"D Poli","year":"2009","unstructured":"Poli D, Antonucci E, Grifoni E et al (2009) Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention. Thromb Haemost 101:367\u2013372","journal-title":"Thromb Haemost"},{"key":"805_CR42","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","volume":"31","author":"The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","year":"2010","unstructured":"The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) (2010) Guidelines for the management of atrial fibrillation. Eur Heart J 31:2369\u20132429","journal-title":"Eur Heart J"},{"key":"805_CR43","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/01.STR.0000198839.61112.ee","volume":"37","author":"H Sato","year":"2006","unstructured":"Sato H, Ishikawa K, Kitabatake A, Japan Atrial Fibrillation Stroke Trial Group et al (2006) Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial. Stroke 37:447\u2013451","journal-title":"Stroke"},{"key":"805_CR44","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1161\/STROKEAHA.110.590257","volume":"41","author":"GY Lip","year":"2010","unstructured":"Lip GY, Frison L, Halperin JL et al (2010) Identifying patients at high risk for stroke despite anticoagulation. A comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort. Stroke 41:2731\u20132738","journal-title":"Stroke"},{"key":"805_CR45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1540-8167.2010.01858.x","volume":"22","author":"D Poli","year":"2011","unstructured":"Poli D, Lip GYH, Antonucci E et al (2011) Stroke risk stratification in a \u201creal-world\u201d elderly anticoagulated atrial fibrillation population. J Cardiovasc Electrophysiol 22:25\u201330","journal-title":"J Cardiovasc Electrophysiol"},{"key":"805_CR46","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1378\/chest.11-2304","volume":"141","author":"JJ You","year":"2012","unstructured":"You JJ, Singer DE, Howard PA et al (2012) Antithrombotic Therapy for Atrial Fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence-based Clinical Practice Guidelines. Chest 141:531\u2013575","journal-title":"Chest"},{"key":"805_CR47","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM199704033361401","volume":"336","author":"PM Ridker","year":"1997","unstructured":"Ridker PM, Cushman M, Stampfer MJ et al (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973\u2013979","journal-title":"N Engl J Med"},{"key":"805_CR48","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1161\/hs1101.098151","volume":"32","author":"NS Rost","year":"2001","unstructured":"Rost NS, Wolf PA, Kase CS et al (2001) Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham Study. Stroke 32:2575\u20132579","journal-title":"Stroke"},{"key":"805_CR49","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.amjcard.2004.06.011","volume":"94","author":"SK Thambidorai","year":"2004","unstructured":"Thambidorai SK, Parakh K, Martin DO et al (2004) Relation of C-reactive protein correlates with risk of thromboembolism in patients with atrial fibrillation. Am J Cardiol 94:805\u2013807","journal-title":"Am J Cardiol"},{"key":"805_CR50","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ahj.2004.01.026","volume":"148","author":"DS Conway","year":"2004","unstructured":"Conway DS, Buggins P, Hughes E et al (2004) Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. Am Heart J 148:462\u2013466","journal-title":"Am Heart J"},{"key":"805_CR51","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0002-9149(02)02534-1","volume":"90","author":"V Pengo","year":"2002","unstructured":"Pengo V, Filippi B, Biasiolo A et al (2002) Association of the G20210A mutation in the factor II gene with systemic embolism in nonvalvular atrial fibrillation. Am J Cardiol 90:545\u2013547","journal-title":"Am J Cardiol"},{"key":"805_CR52","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1161\/01.STR.0000183620.06179.7b","volume":"36","author":"D Poli","year":"2005","unstructured":"Poli D, Antonucci E, Cecchi E et al (2005) Culprit factors for the failure of well conducted warfarin therapy to prevent ischemic events in patients with atrial fibrillation: the role of homocysteine. Stroke 36:2159\u20132163","journal-title":"Stroke"},{"key":"805_CR53","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","volume":"2","author":"TV Glotzer","year":"2009","unstructured":"Glotzer TV, Daoud EG, Wyse DG et al (2009) The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol 2:474\u2013480","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"805_CR54","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/STROKEAHA.110.609297","volume":"42","author":"G Boriani","year":"2011","unstructured":"Boriani G, Botto GL, Padeletti L et al (2011) Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring. Stroke 42:1768\u20131770","journal-title":"Stroke"},{"key":"805_CR55","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1136\/bmj.c4249","volume":"341","author":"M Lee","year":"2010","unstructured":"Lee M, Saver JL, Liao HW et al (2010) Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ 341:4249","journal-title":"BMJ"},{"key":"805_CR56","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ahj.2009.06.031","volume":"158","author":"H Watanabe","year":"2009","unstructured":"Watanabe H, Watanabe T, Sasaki S et al (2009) Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J 158:629\u2013636","journal-title":"Am Heart J"},{"key":"805_CR57","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1160\/TH10-07-0491","volume":"104","author":"DA Garcia","year":"2010","unstructured":"Garcia DA, Lopes RD, Hylek EM (2010) New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs. Thromb Haemost 104:1099\u20131105","journal-title":"Thromb Haemost"},{"key":"805_CR58","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/europace\/eur126","volume":"13","author":"GYH Lip","year":"2011","unstructured":"Lip GYH, Andreotti F, Fauchier L et al (2011) Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis. Europace 13:723\u2013746","journal-title":"Europace"},{"key":"805_CR59","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1136\/hrt.75.2.200","volume":"75","author":"GY Lip","year":"1996","unstructured":"Lip GY, Zarifis J, Watson RD et al (1996) Physician variation in the management of patients with atrial fibrillation. Heart 75:200\u2013205","journal-title":"Heart"},{"key":"805_CR60","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters R, Lane DA, Nieuwlaat R et al (2010) A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 138:1093\u20131100","journal-title":"Chest"},{"key":"805_CR61","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","volume":"151","author":"BF Gage","year":"2006","unstructured":"Gage BF, Yan Y, Milligan PE et al (2006) Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J 151:713\u2013719","journal-title":"Am Heart J"},{"key":"805_CR62","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","volume":"374","author":"DR Holmes","year":"2009","unstructured":"Holmes DR, Reddy VY, Turi ZG, PROTECT AF Investigators et al (2009) Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 374:534\u2013542","journal-title":"Lancet"},{"key":"805_CR63","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1378\/chest.114.5_Supplement.579S","volume":"114","author":"A Laupacis","year":"1998","unstructured":"Laupacis A, Albers G, Dalen J et al (1998) Antithrombotic therapy in atrial fibrillation. Chest 114:579\u2013589","journal-title":"Chest"},{"key":"805_CR64","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.1994.00420130036007","volume":"154","author":"A Laupacis","year":"1994","unstructured":"Laupacis A, Boysen G, Connolly S et al (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Int Med 154:1449\u20131457","journal-title":"Arch Int Med"},{"key":"805_CR65","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/bmj.312.7022.45","volume":"312","author":"GY Lip","year":"1996","unstructured":"Lip GY, Lowe GD (1996) ABC of atrial fibrillation. Anti-thrombotic treatment for atrial fibrillation. Br Med J 312:45\u201349","journal-title":"Br Med J"},{"key":"805_CR66","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/archinte.163.8.936","volume":"163","author":"C Walraven Van","year":"2003","unstructured":"Van Walraven C, Hart RG, Wells GA et al (2003) A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. Arch Int Med 163:936\u2013943","journal-title":"Arch Int Med"},{"key":"805_CR67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-116-1-1","volume":"116","author":"The Stroke Prevention in Atrial Fibrillation Investigators Predictors of thromboembolism in atrial fibrillation","year":"1992","unstructured":"The Stroke Prevention in Atrial Fibrillation Investigators Predictors of thromboembolism in atrial fibrillation (1992) Predictors of thromboembolism in atrial fibrillation:I. Clinical features of patients at risk. Ann Int Med 116:1\u20135","journal-title":"Ann Int Med"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-012-0805-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-012-0805-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-012-0805-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T15:16:12Z","timestamp":1562253372000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-012-0805-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":67,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["805"],"URL":"https:\/\/doi.org\/10.1007\/s11739-012-0805-x","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}